Related Experiment Video
Updated: Aug 23, 2025

Characterization of Inflammatory Responses During Intranasal Colonization with Streptococcus pneumoniae
Published on: January 17, 2014
The Clinical Features and Management of Empyema Caused by Streptococcus constellatus
Jinyan Lin1, Yu Zhang1, Chongxi Bao1
1Pulmonary and Critical Care Medicine Ward, Guangxi Medical University First Affiliated Hospital, Nanning, People's Republic of China.
Background:
Streptococcus constellatus, a commensal, plays an important role in purulent infections. It has been reported as aggressive pathogen causing pleural empyema. But the role of S. constellatus in empyema has not been taken seriously. There are no studies about clinical characteristics of empyema caused by S. constellatus domestically and abroad. This study aimed to explore the clinical features and management of empyema caused by S. constellatus.
Methods:
A retrospective review of 9 patients diagnosed with empyema caused by S. constellatus in a hospital between January 2010 and August 2021 was performed.
Results:
S. constellatus empyema were mostly seen in old males (66.7%) with comorbid diseases. The high-risk factors include diabetes mellitus, oral infection, and oral surgery. All were unilateral encapsulated empyema (right-side, 55.6%), diagnosed with pneumonia (bilateral pneumonia, 88.9%; ipsilateral lung abscess, 44.4%). 33.3% of patients had S. constellatus and anaerobes co-isolated. S. constellatus were sensitive to penicillin G, linezolid, levofloxacin, vancomycin, ceftriaxone, and chloramphenicol, resistant to erythromycin, tetracycline, and clindamycin. 33.3% of the patients needed ventilator support. The primary treatment to S. constellatus empyema was timely pus drainage, intravenous antibiotics, and enough nutrition support, intrapleural fibrinolytics and surgery (VAST recommended first) in necessity.
Conclusion:
S. constellatus may cause pneumonia and lung abscess first and then spread to cause empyema mainly in old males with comorbid diseases. S. constellatus often co-isolated with anaerobes in empyema. Antibiotics should cover simultaneously both S. constellatus and anaerobes.
Insights
Streptococcus constellatus can cause serious pleural empyema, particularly in older males with underlying health conditions. Treatment requires prompt drainage, antibiotics targeting both S. constellatus and anaerobes, and supportive care.
Area of Science:
- Medical Microbiology
- Infectious Diseases
- Pulmonology
Background:
- Streptococcus constellatus, a common commensal, is increasingly recognized as a pathogen in purulent infections.
- While S. constellatus can cause aggressive pleural empyema, its specific clinical features and management remain understudied.
- This study addresses the gap in knowledge regarding S. constellatus empyema.
Purpose of the Study:
- To investigate the clinical characteristics of empyema caused by Streptococcus constellatus.
- To explore the effective management strategies for S. constellatus empyema.
Main Methods:
- A retrospective review of 9 patients diagnosed with S. constellatus empyema between January 2010 and August 2021.
- Analysis of patient demographics, risk factors, clinical presentations, microbiological findings, and treatment outcomes.
Main Results:
- S. constellatus empyema predominantly affects elderly males with comorbidities like diabetes and oral infections/surgery.
- Common presentations include unilateral encapsulated empyema, pneumonia, and lung abscess; S. constellatus is often co-isolated with anaerobes.
- The pathogen shows sensitivity to penicillin G, linezolid, levofloxacin, vancomycin, ceftriaxone, and chloramphenicol, but resistance to erythromycin, tetracycline, and clindamycin.
Conclusions:
- S. constellatus can lead to pneumonia, lung abscess, and subsequent empyema, especially in vulnerable male populations.
- Co-infection with anaerobes is frequent, necessitating broad-spectrum antibiotic coverage.
- Optimal management involves timely pus drainage, appropriate antibiotics, nutritional support, and potentially intrapleural fibrinolytics or surgery.
More Related Videos
Related Concept Videos
Esophageal Perforation-II: Clinical Manifestations and Management
Clinical Manifestations:
Acute Pyelonephritis II: Diagnostic Studies and Management
Tonsillitis II: Management
Pneumonia III: Complications and Assessment
Tonsillitis I: Introduction
Etiology
Three primary contributing factors have been identified.
Esophageal Strictures-II: Clinical Features and Management
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...

